Ayr Wellness Inc. (OTCMKTS:AYRWF - Free Report) - Equities research analysts at Atb Cap Markets dropped their FY2024 earnings per share (EPS) estimates for Ayr Wellness in a research note issued on Wednesday, November 13th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of ($1.34) per share for the year, down from their previous estimate of ($1.15). Atb Cap Markets has a "Strong Sell" rating on the stock. The consensus estimate for Ayr Wellness' current full-year earnings is ($1.30) per share. Atb Cap Markets also issued estimates for Ayr Wellness' Q4 2024 earnings at ($0.29) EPS and FY2025 earnings at ($0.98) EPS.
A number of other analysts have also recently issued reports on AYRWF. Roth Capital raised Ayr Wellness to a "strong-buy" rating in a research note on Friday, November 8th. Roth Mkm lowered their price objective on shares of Ayr Wellness from $3.50 to $3.00 and set a "buy" rating for the company in a research report on Thursday.
Read Our Latest Stock Report on AYRWF
Ayr Wellness Trading Down 1.3 %
OTCMKTS AYRWF opened at $0.77 on Monday. Ayr Wellness has a one year low of $0.71 and a one year high of $4.09. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.59 and a quick ratio of 0.67. The firm has a market cap of $87.90 million, a P/E ratio of -0.35 and a beta of 2.00. The stock's 50-day moving average is $1.82 and its 200-day moving average is $1.98.
About Ayr Wellness
(
Get Free Report)
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Read More
Before you consider Ayr Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ayr Wellness wasn't on the list.
While Ayr Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
